Goodwill Pharma has signed a strategic agreement to transfer the rights to the FORTACELL brand to HEMOFARM STADA, entrusting this reputable pharmaceutical partner with the markets of Serbia, Bosnia and Herzegovina, North Macedonia, Montenegro, and Albania. This decision represents a significant step in the regional expansion of the brand, while simultaneously preserving and further developing […]
Szeged, 30 June 2025 – At a ceremonial press conference held in the Grand Hall of the Goodwill Pharma Campus, it was officially announced that Goodwill Pharma Plc. will become the naming sponsor of the Szeged men’s and women’s water polo teams in the future. As part of this cooperation, the team’s new name will […]
The Vitafoods Europe Exhibition has officially started in Barcelona, and Goodwill Pharma Plc is proudly taking part. Vitafoods Europe is one of the most significant international exhibitions and conferences in the field of dietary supplements, functional foods, and health-conscious living. This annual event showcases the latest trends, innovations, and scientific breakthroughs, bringing together the most […]
Goodwill Pharma Plc. is pleased to announce its partnership with Aversi, a leading pharmaceutical company in Georgia, to introduce Pepto Soda Effervescent Powder to the Georgian market. This collaboration marks a significant step in expanding Goodwill Pharma’s presence in the region while providing an innovative solution for digestive health. A Solid Partnership for Better Digestive […]
Goodwill Pharma Plc. has partnered with Harken Derm to distribute the innovative Harken Derm SUNPRO+ skincare product in the United States. Goodwill Pharma Plc. is delighted to announce a key partnership with Harken Derm. Together, they are introducing Harken Derm SUNPRO+, a dietary supplement that has the potential to revolutionize skin protection from within. This […]
Goodwill Pharma Plc.’s social responsibility in the resuscitation education program for school-age children In Hungary, 70 people die every day from sudden cardiac arrest, i.e., circulation failure, which adds up to more than 25,000 people per year. For every minute that passes without resuscitation, the chance of survival decreases by 10%. Lay helpers are key […]
Goodwill Pharma Plc. plays a significant role in the pharmaceutical and therapeutic product markets in Central and Eastern Europe, primarily in Hungary, Serbia, and Poland. Additionally, it is present in Kosovo, Bosnia and Herzegovina, Macedonia, Slovakia, the Czech Republic, and Romania. We are proud to announce that on September 17, 2024, Goodwill Pharma expanded its […]
-Another milestone of business excellence- Goodwill Pharma Plc. has once again demonstrated its leadership in both market entry and corporate management by winning Deloitte’s “Best Managed Companies” award. Deloitte Private’s global business mentoring program was created to support and recognize locally owned private companies. The award is given to companies that excel not only through […]
We were delighted to take part in the 44th Congress of the Polish Society of Orthopedics and Traumatology, which was held this year from September 12-14 at the International Congress Center in Katowice. The event attracted over 1,050 participants, including specialists and surgical professionals, who shared their knowledge and experiences through numerous lectures and roundtable […]
Szeged, September 2, 2024 – Novartis Hungária and Goodwill Pharma have entered into a partnership agreement. The primary goal of the partnership is to optimize portfolio strategies, which can contribute to enhancing the security of domestic pharmaceutical supply. In the long term, however, the collaboration between the two companies may extend to a regional level […]